<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>57(1)</volume><submitter>Song Q</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Anorexia is a common problem among patients with chronic obstructive pulmonary disease (COPD). This study aimed to analyze the clinical characteristics and prognosis of COPD patients with anorexia.&lt;h4>Methods&lt;/h4>This prospective cohort study included patients registered in the RealDTC study between May 2023 and February 2024. Demographic on COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) scores, pulmonary function, number of exacerbations, inhalation therapy, and the section of anorexia/cachexia subscale (A/CS)-12 of Functional Assessment of Anorexia/Cachexia Therapy (FAACT) scores were collected. A FAACT A/CS-12 score of ≤ 30 was used to identify patients with anorexia. All patients were followed up for one year to collect exacerbations, and mor</pubmed_abstract><journal>Annals of medicine</journal><pagination>2590186</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12642890</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The clinical characteristics and prognosis in chronic obstructive pulmonary disease patients with anorexia.</pubmed_title><pmcid>PMC12642890</pmcid><pubmed_authors>Chen P</pubmed_authors><pubmed_authors>Peng D</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Song Q</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Zeng Y</pubmed_authors><pubmed_authors>Lin L</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors></additional><is_claimable>false</is_claimable><name>The clinical characteristics and prognosis in chronic obstructive pulmonary disease patients with anorexia.</name><description>&lt;h4>Background&lt;/h4>Anorexia is a common problem among patients with chronic obstructive pulmonary disease (COPD). This study aimed to analyze the clinical characteristics and prognosis of COPD patients with anorexia.&lt;h4>Methods&lt;/h4>This prospective cohort study included patients registered in the RealDTC study between May 2023 and February 2024. Demographic on COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) scores, pulmonary function, number of exacerbations, inhalation therapy, and the section of anorexia/cachexia subscale (A/CS)-12 of Functional Assessment of Anorexia/Cachexia Therapy (FAACT) scores were collected. A FAACT A/CS-12 score of ≤ 30 was used to identify patients with anorexia. All patients were followed up for one year to collect exacerbations, and mor</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-05T19:36:02.163Z</modification><creation>2026-05-21T03:10:55.413Z</creation></dates><accession>S-EPMC12642890</accession><cross_references><pubmed>41268634</pubmed><doi>10.1080/07853890.2025.2590186</doi></cross_references></HashMap>